Pediatric Amblyopia Risk Investigation Study (PARIS)

Area of Science:

• Ophthalmology
• Pediatric Health
• Vision Science

Background:

• Pediatric vision screening is crucial for early detection of amblyopia and refractive errors.
• Health extenders play a vital role in delivering primary care services, including vision screening.
• Assessing the efficacy of different screening modalities is essential for optimizing pediatric eye care.

Purpose of the Study:

• To evaluate the learning curve, testability, and reliability of vision screening methods.
• To compare noncycloplegic autorefraction (NCAR), LEA visual acuity (LEA), and stereopsis (RDE) administered by pediatric health extenders.
• To determine the efficiency and accuracy of these modalities in a pediatric population.

Main Methods:

• A prospective masked clinical trial involving 200 children aged 3 to 6 years.
• Screening for amblyopia risk factors using LEA, RDE, and NCAR by physician extenders.
• Comparison of screening results with a comprehensive eye examination by an ophthalmologist or optometrist.

Main Results:

• NCAR and RDE screening times decreased by 40% during the study, with NCAR demonstrating high reliability for astigmatism and moderate reliability for spherical equivalent.
• Overall testability was high for all modalities (92-96%), though LEA showed lower testability in 3-year-olds (73%).
• NCAR proved significantly faster and more reliable for detecting refractive errors compared to LEA, especially in younger children.

Conclusions:

• NCAR is a rapid and reliable tool for pediatric vision screening, particularly for detecting astigmatism and spherical refractive errors by physician extenders.
• While LEA has lower initial costs, it is time-consuming and less reliable for very young children.
• NCAR shows promise as an efficient screening tool for refractive amblyopia in younger children, warranting further investigation into its sensitivity and specificity.